Composition suitable for improving hair growth, hair health, and hair loss
A nighttime composition with natural extracts and amino acids, targeting hair follicle detoxification and sleep, addresses the limitations of existing hair loss treatments by enhancing hair growth and reducing hair loss effectively.
Patent Information
- Application Number
- PCT/EP2026/063854
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-13
- Filing Date
- 2026-05-12
- Publication Date
- 2026-11-19
AI Technical Summary
Existing hair loss treatments, including pharmaceutical drugs and cosmetic products, have limitations such as the need for continuous use or systemic side effects, and oral supplements do not align with the circadian rhythms of the hair follicle, impacting their effectiveness in promoting hair growth and preventing hair loss.
A composition comprising natural extracts (Pleurotus ostreatus, Chlorella, Schisandra) and amino acids (L-Arginine, L-Alanine, L-Glycine, L-Serine, L-Lysine, L-Leucine, L-Proline) with melatonin, designed for nighttime application, enhances cellular detoxification, regeneration, and restful sleep to support hair health and growth, minimizing adverse effects.
The composition optimally supports hair growth and reduces hair loss by leveraging nocturnal repair cycles, improving hair strength, hydration, and overall hair health, while avoiding common treatment side effects.
Smart Images

Figure IMGF000028_0001_TABLE 
Figure IMGF000028_0002_TABLE 
Figure IMGF000029_0001_TABLE
Abstract
Description
[0001] Composition suitable for improving hair growth, hair health, and hair loss
[0002] This application claims the benefit of European Patent Application EP25382483 filed 13 May 2025.
[0003] Technical Field
[0004] It relates to the field of compositions and its uses for improving hair appearance, promoting hair health, hair growth, and preventing hair loss.
[0005] Background Art
[0006] Hair loss affects a large number of people globally, causing significant concern regarding appearance and well-being. The causes are varied and include genetic factors, hormonal changes (particularly involving androgens), immune system responses, environmental damage, age-related oxidative stress, and the body's reactions to chronic stress or disrupted sleep. Major types of hair loss include androgenetic alopecia (male and female pattern baldness), alopecia areata, and telogen effluvium.
[0007] Each hair grows from a follicle that circles through three stages: growth (anagen), regression (catagen), and rest (telogen). When this cycle is upset, by the hormone dihydrotestosterone (DHT), by an immune attack on the bulb, or by sudden stress, hair becomes thinner and may fall out. Research shows that follicles follow a daily, or circadian, clock. If the body clock and follicle clock fall out of sync, the start of anagen is delayed and cell growth slows (see Ye Niu et al.; “Overwiew of the Circadian Clock in the Hair Follicle Cycle”; Biomolecules 2023, vol. 13, 1068).
[0008] Current hair loss treatments include pharmaceutical drugs, cosmetic products, and supplements. Established drug treatments are topical minoxidil (applied to the scalp) and oral finasteride (taken by mouth). The exact way minoxidil works is not fully known, but it is recognized to stimulate hair growth. Finasteride acts by blocking a specific enzyme (type II 5-alpha-reductase) in the hair follicle. This reduces the production of DHT, a key hormone involved in pattern hair loss. While these drugs can be effective, they have limitations, such as the need for continuous use (minoxidil) or the risk of side effects affecting the whole body (finasteride).
[0009] Cosmetic formulations, such as topical lotions and serums, often contain ingredients aimed at improving scalp microcirculation, providing antioxidant support, or exerting antiinflammatory effects. Notably, topical preparations containing melatonin, appliednocturnally , have been investigated for their potential to increase the percentage of hairs in the anagen phase, seemingly without significant systemic hormonal alterations (see Fischer TW, Burmeister G, Schmidt HW, Elsner P. Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial. Br J Dermatol. 2004 Feb;150(2):341-5.). However, these represent localized, leave-on treatments applied directly to the scalp and are distinct from systemic interventions.
[0010] Furthermore, many existing oral supplements intended to support hair health are typically formulated for, or conventionally taken during, daytime hours. This administration schedule may not optimally align with the intrinsic circadian rhythms of the hair follicle and the heightened biological repair and regenerative activities occurring during the nocturnal period.
[0011] Therefore, there exists an unmet need in the art for a well-tolerated composition, particularly one suitable for convenient oral administration, that would ideally leverage the body's natural nocturnal repair cycles and the circadian biology of the hair follicle to more effectively support healthy hair growth, improve hair appearance, and potentially prevent hair loss, while minimizing the limitations associated with existing treatment modalities and administration schedules.
[0012] Summary of Invention
[0013] The present invention provides a composition, particularly formulated for nighttime application, designed to reduce hair loss and promote hair growth. It uniquely addresses key underlying factors by focusing on three principal areas relevant to nocturnal physiology and hair health: (1) enhancing cellular detoxification and autophagy within the hair follicle environment; (2) supporting the regeneration and repair processes of hair structures; and (3) promoting restful sleep and reducing physiological stress, factors known to influence hair cycling. This targeted approach aims to improve hair condition by using a combination of selected ingredients, potentially minimizing adverse effects associated with some conventional treatments.
[0014] Inventors have found that a combination of specific compounds according to the present invention such as natural extracts and amino acids which allow maximization of positive effects on the hair while avoiding the usual side effects of the common pharmacological treatments indicated for hair loss, further enhancing the overall treatment efficacy and user experience. These compounds are a) at least a natural extract A selected from the group consisting of Pleurotus ostreatus extract, and Chlorella extract selected fromChlorella vulgaris and Chlorella pyrenoidosa extract; b) at least an amino acid selected from the group consisting of L- Arginine, L- Alanine, L-Glycine, L- Serine, L- Lysine, L-Leucine, and L- Proline; and c) Melatonin; or Schisandra extract; ora combination of melatonin with Schisandra extract.
[0015] Therefore, in a first aspect, the present invention relates to a composition for promoting hair growth, specifically natural hair growth, the prevention and / or reduction of hair loss, specifically natural hair loss, promoting hair health, or any combination thereof comprising: a) at least a natural extract A selected from the group consisting of Pleurotus ostreatus extract, and Chlorella extract selected from Chlorella vulgaris and Chlorella pyrenoidosa extract; b) at least an amino acid selected from the group consisting of L- Arginine, L-Alanine, L-Glycine, L- Serine, L- Lysine, L- Leucine, and L- Proline; and c) Melatonin; or plant extract B which is Schisandra extract; or a combination of melatonin with Schisandra extract. Promoting hair health means improving one or more properties of hair selected from strength, breakage resistance, hydration, smoothness, gloss, softness, and elasticity.
[0016] The oral composition may be combined together with vitamins, amino acids, amino acids precursors, minerals, carbohydrates, fats, flavorings, herbal extracts, sweeteners, and antioxidants. The inventors have found that such oral composition provides several benefits on the treatment of hair, including also cosmetic benefits.
[0017] In a second aspect, the present invention relates to the use of a composition as defined above, in the prevention and / or reduction of hair loss, specifically natural hair loss; in promoting hair health; in promoting hair growth, specifically natural hair growth; or any combination thereof.
[0018] Additionally, the inventors have recognized that providing continuous support to the scalp and hair follicles throughout the full 24-hour cycle further optimizes the conditions for robust hair growth and the reduction of hair loss. Supplementing the targeted nighttime composition of the present invention, with a dedicated daytime administration aimed at reducing hair loss and promoting hair growth, has been found to improve the overall outcomes and user-perceived benefits.
[0019] In a third aspect, the present invention relates to a kit for preventing and / or treating hair loss; promoting hair growth; or both, specifically, a kit for promoting natural hair growth, the prevention and / or reduction of natural hair loss; or any combination, as well as, for promoting hair health, comprising:
[0020] a) a composition as defined above for nighttime administration,
[0021] b) a composition for reducing hair loss and promoting hair growth for daytimeadministration; and
[0022] c) instructions for the administration of the compositions.
[0023] Detailed description of the invention
[0024] All terms as used herein in this application, unless otherwise stated, shall be understood in their ordinary meaning as known in the art. Other more specific definitions for certain terms as used in the present application are as set forth below and are intended to apply uniformly through-out the specification and claims unless an otherwise expressly set out definition provides a broader definition.
[0025] For the purposes of the invention, any ranges given include both the lower and the upper endpoints of the range. Ranges given, such as temperatures, quantities, sizes, and alike, should be considered approximate, unless specifically stated.
[0026] The composition of the present invention may be considered a food supplement. The term “food supplement” refers to concentrated sources of nutrients (i.e. minerals and vitamins) or other substances with a nutritional or physiological effect that are marketed in “dose” form. A wide range of nutrients and other ingredients might be present in food supplements, including, but not limited to, vitamins, minerals, amino acids, essential fatty acids, fiber and various plants and herbal extracts. The food supplement for natural hair loss of the present invention refers to a composition comprising phytochemical ingredients, designed to promote natural hair growth and reduce natural hair loss without the use of synthetic drugs.
[0027] The term “phytochemical ingredients” refers to naturally occurring chemical compounds in plants.
[0028] For the purposes of the invention, commercial extracts can be used for any of the extracts present in the composition.
[0029] The term “room temperature” as disclosed herein refers to a temperature of the environment, without heating or cooling, and is generally comprised from 20 to 25 °C.
[0030] The expression "effective amount”, refers to the amount of a compound that, when administered, is sufficient to provide for the intended uses of the invention. The effective amount of the active ingredients will vary with the duration of the treatment, the specific combination of active ingredients employed, its particular formulation and the use of acceptable carriers utilized, and like factors. The safety of the active ingredients issupported by their history of traditional use as food.
[0031] As used herein, “natural hair loss” refers to the physiological shedding of hair that occurs as part of the normal hair - growth cycle, in the absence of any pathological, chemical, mechanical or environmental insult.
[0032] As used herein, “promoting natural hair growth” refers to enhancing one or more parameters of the hair growth cycle, leading to an increase in the rate, density, thickness or length of hair shafts under physiological (non-pathological) conditions.
[0033] As used herein, “promoting hair health” refers to improving one or more properties of hair selected from strength, breakage resistance, hydration, smoothness, gloss, softness, and elasticity. Specifically, it refers to improving one, or combinations of two, three, four, five, six, seven, or eight properties from those mentioned.
[0034] As used herein, “complementary supplement” refers to a nutritional formulation, taken in addition to a subject’s normal diet or primary hair-care regimen, comprising one or more ingredients and dosages of which are selected to promote hair-growth and / or reduce hairloss by supporting follicular health, modulating the hair-growth cycle, or mitigating oxidative and inflammatory stress.
[0035] As used herein, “nighttime” refers to the period of each 24-hour cycle during which the subject is normally at rest or sleeping, for example the time between about 6:00 p.m. of a given day and about 6:00 a.m. of the following day (i.e., the interval from sunset to sunrise, adjusted for local time).
[0036] As used herein, “daytime” refers to the period of each 24-hour cycle during which the subject is normally awake and active, for example the time between about 6:00 a.m. and about 6:00 p.m. of the same calendar day (i.e., the interval from sunrise to sunset, adjusted for local time).
[0037] As mentioned above, one aspect of the present invention relates to a composition for promoting natural hair growth, the prevention and / or reduction of natural hair loss, promoting hair health, or any combination thereof comprising: a) at least a natural extract A selected from the group consisting ofPleurotus ostreatus extract, and Chlorella extract selected from Chlorella vulgaris and Chlorella pyrenoidosa extract; b) at least an amino acid selected from the group consisting of L- Arginine, L- Alanine, L-Glycine, L- Serine, L-Lysine, L- Leucine, and L- Proline; and c) melatonin; or a plant extract B which is Schisandra extract; or a combination thereof.In a particular embodiment, the composition for promoting natural hair growth, the prevention and / or reduction of natural hair loss, promoting hair health or any combination thereof, comprising: a) at least a natural extract A which is Pleurotus ostreatus extract; b) at least an amino acid selected from the group consisting of L- Arginine, L- Alanine, L-Glycine, L- Serine, L- Lysine, L- Leucine, and L- Proline; and
[0038] c) melatonin; or a plant extract B which is Schisandra extract; or a combination of melatonin with schisandra extract;
[0039] wherein promoting hair health means improving one or more properties of hair selected from strength, breakage resistance, hydration, smoothness, gloss, softness, and elasticity.
[0040] In a particular embodiment, in combination with any of the embodiments above or below, the combination of element b) is a combination of one compound selected from at least an amino acid selected from the group consisting of L- Arginine, L- Alanine, L- Serine, L-Lysine, and L- Leucine.,.
[0041] In another particular embodiment, element c) melatonin.
[0042] In another particular embodiment, element c) is Schisandra extract.
[0043] In a particular embodiment, the composition according to the present invention may further comprises Sylibum marianum extract.
[0044] In a particular embodiment, the composition according to the present invention may further comprises Camellia sinensis extract or Chamomilla extract.
[0045] The Pleurotus ostreatus (Oyster Mushroom) extract is characteristically prepared as a light brown or tan powder, obtained primarily from the dried fruiting bodies of the fungus, although mycelial extracts are also possible. The extraction process utilizes hot water or aqueous ethanol solutions. The extract's solubility in water can vary from partial to significant depending on the specific extraction protocol and target compounds. Extraction ratios can range broadly, for instance, from approximately 4:1 to 20:1 or higher if concentrating specific fractions. This extract is standardized to contain a minimum of 2% in ergothioneine by weight. Particle size is generally controlled, often within the 60-100 mesh range. This extract is typically produced as GMO-free and non-irradiated.
[0046] The Chlorella pyrenoidosa and the Chlorella vulgaris extract are presented as a dark green powder derived from the whole dried biomass of the microalga. Extraction is typically carried out using food-grade solvents such as water and / or ethanol, potentiallyinvolving specific processes to concentrate target compounds like polyamines. This extract is standardized to contain a minimum of 1% spermidine by weight. Besides spermidine, it contains characteristic Chlorella components such as chlorophyll and proteins. It generally exhibits partial solubility in water. The particle size typically ranges from approximately 60 to 80 mesh. The material is preferably specified as being GMO-free and has not been subjected to irradiation.
[0047] The Silybum marianum (Milk Thistle) dry extract is typically presented as a yellowish-brown to brown powder, derived from the dried fruits (seeds) of the plant. Common extraction solvents include ethanol, ethyl acetate, methanol, or mixtures thereof, often with water. This extract is specifically standardized to contain a high percentage of silymarin (>70 % by weight, more particularly >80% by weight). It may contain about 20-30% silybin by weight, a major active flavonolignan within the Silymarin complex, typically quantified via High-Performance Liquid Chromatography (HPLC). It exhibits poor solubility in water but demonstrates better solubility in organic solvents like ethanol or acetone.
[0048] The Schisandra extract, derived from the species Schisandra chinensis, is characteristically a yellowish-brown to brown powder obtained from the dried ripe fruits (berries) of the plant. Extraction is performed using ethanol or aqueous ethanol solutions, as this solvent system is effective for isolating the primary bioactive constituents.
[0049] Consequently, the extract generally exhibits poor solubility in water but is soluble in ethanol and similar organic solvents. Such extracts are typically standardized based on their total schisandrin content (e.g., commonly ranging from 1% to 9% by weight) or the content of one or more specific schisandrins, usually quantified by UV-Vis spectrophotometry or HPLC-UV. The particle size is commonly controlled to fall within the 60-100 mesh range. This extract is preferably specified as GMO-free and non-irradiated.
[0050] The Camellia sinensis (green tea) extract is a decaffeinated light brown, pale greenish, yellowish, yellowish-brown to brown powder, obtained from the leaves of the Camellia sinensis plant. The extraction process commonly employs water or aqueous ethanol to isolate L-Theanine, a water-soluble compound, followed by purification steps that reduce caffeine content to negligible levels while concentrating L-Theanine. This extract is specifically standardized to contain about 40% or higher by weight of L-Theanine by weight, typically verified by HPLC analysis. Owing to the nature of L-Theanine, the extract is readily soluble in water. While enriched for L-Theanine, it may retain varying residual levels of other native green tea constituents, such as polyphenols (catechins), depending on the refinement level. The particle size typically falls within a 60-100 mesh range. The extract is designated as GMO-free and has not undergone irradiation.The Chamomile extract, typically derived from German Chamomile (Matricaria chamomilla L. / Matricaria recutita L.), appears as a fine, yellowish-brown to dark brown powder. It is obtained from the dried flowers of the plant. The extract is standardized to its apigenin content around 1-1.5% by weight, normally determined by HPLC. Particle size for powders is commonly controlled, often within the 60-100 mesh range. As with other botanical extracts, it is preferably specified as GMO-free and non-irradiated.
[0051] In a particular embodiment, the composition as defined above is that which is an oral composition. In another particular embodiment, the oral composition as defined above is that which is a liquid oral composition.
[0052] In another particular embodiment, the composition as defined above is that where: a) the at least natural extract A is selected from the group consisting of Pleurotus ostreatus extract, and Chlorella extract selected from Chlorella vulgaris and Chlorella pyrenoidosa extract; b) the at least an amino acid is selected from the group consisting of L- Arginine, L- Alanine, L-Glycine, L- Serine, and L- Lysine; and c) melatonin; the at least a plant extract B which is, Schisandra extract. In a more particular embodiment, the composition further comprises green tea extract.
[0053] In another particular embodiment, the composition as defined above is that where: a) the at least natural extract A is a Chlorella extract selected from Chlorella vulgaris and Chlorella pyrenoidosa extract; b) the at least an amino acid is selected from the group consisting of L- Arginine, L- Alanine, L-Glycine, L- Serine, and L- Lysine; and c) melatonin; the at least a plant extract B is Schisandra extract, In a more particular embodiment, the composition further comprises green tea extract.
[0054] In another particular embodiment, the composition as defined above comprising:
[0055] a) Pleurotus ostreatus extract; b) the at least an amino acid is selected from the group consisting of L- Arginine, and L- Alanine; and c) Melatonin.
[0056] In another particular embodiment, the composition as defined above comprising:
[0057] a) Pleurotus ostreatus extract; b) the at least an amino acid is selected from the group consisting of L- Arginine, and L- Alanine; and c) Schisandra extract.
[0058] In another particular embodiment, the composition as defined above comprising:
[0059] a) Pleurotus ostreatus extract; b) L- Arginine; and c) Melatonin.
[0060] As used herein, the term "natural extract A" encompasses one or more plant-derived or fungus-derived extracts, or a combination thereof. These extracts exhibit detoxifyingproperties relevant to the scalp and / or hair follicles. These properties are understood to contribute to a healthier scalp environment conducive to hair growth. Such detoxifying properties may include, but are not limited to: a) Purification: Assisting in the removal of impurities from the scalp surface and potentially from within or around the hair follicle opening; impurities can encompass environmental pollutants, residues from cosmetic products, excess sebum, and metabolic byproducts; b) Neutralization / Protection:
[0061] Possessing antioxidant activity capable of neutralizing reactive oxygen species (ROS) or other free radicals, thereby mitigating oxidative stress on scalp skin cells and hair follicle cells. Research has indicated that oxidative stress is an important factor causing hair loss. Hair loss occurs when the skin or hair follicles are stimulated by oxidative stress, inflammation or hormonal disorders that disrupt the homeostasis of the hair follicles.
[0062] Numerous research have indicated that oxidative stress is an important factor causing hair loss. The treatment of hair loss can be achieved through both topical and oral antioxidant supplementation, (see e.g. Le Floc'h C, Cheniti A, Connetable S, et al. Effect of a nutritional supplement on hair loss in women. J Cosmet Dermatol. 2015;14(1):76-82; or F. Du et al.; “Oxidative stress in hair follicle development and hair growth: signaling pathways, intervening mechanism and potential of natural antioxidants”, J. Cell. Mol Med, 2024, vol. 28: e18486); c) Cleansing Support: Aiding in the gentle cleansing of the scalp to remove buildup without disrupting the natural barrier function significantly; and / or d) Microenvironment Balancing: Contributing to the maintenance of a balanced and healthy scalp microenvironment, potentially by influencing the scalp microbiome or reducing factors that contribute to scalp irritation or imbalance.
[0063] The natural extract(s) comprising natural extract A may be obtained from various parts of a plant or fungus (e.g., leaves, stems, roots, flowers, seeds, fruiting bodies, mycelium, spores) using any extraction methods known in the art (e.g., aqueous extraction, solvent extraction, supercritical fluid extraction). The defining characteristic of natural extract A within the context of this invention is its functional contribution toward detoxifying the hair follicular environment.
[0064] As used herein, the term “amino acids” designates one or more free amino acids, peptide mixtures, or amino-acid derivatives, alone or in combination, selected for being precursors for both keratin and collagen synthesis. Within the context of the present invention, these properties are essential for the mechanical strength and elasticity of the hair shaft, while the health of the follicular microenvironment benefits from collagen support in the surrounding dermal matrix.
[0065] As used herein, the term "plant extract B" designates one or more plant-derived extracts, or a combination thereof, which have properties associated with stress modulation and thepromotion of conditions favourable for restful sleep. Within the context of this invention, these properties are considered relevant because physiological stress and inadequate sleep can negatively impact the hair growth cycle and overall scalp health. The properties of plant Extract B may include but are not limited to: a) Stress Response Modulation: Exhibiting adaptogenic, calming, or soothing qualities that may help mitigate the physiological responses to stress. This could involve, for example, influencing pathways related to stress hormones (like cortisol) or promoting a sense of relaxation, thereby potentially reducing stress-induced negative effects on hair follicles; b) Promotion of Restful State: Containing compounds known or believed to support relaxation and conditions conducive to achieving better sleep quality. Improved sleep supports the body's natural regenerative and restorative processes, which are important for healthy cellular function, including that of hair follicles; and / or c) The plant extract(s) comprising plant extract B may be obtained from various parts of the plant using various extraction methods known in the art. The defining characteristic of plant extract B within the context of this invention is its functional contribution towards mitigating the negative impacts of stress and poor sleep on the physiological state, thereby supporting conditions more favourable for healthy hair growth and follicle function.
[0066] Extracts forming part of the composition of the present invention which exhibit properties as those described for plant extract B is Schisandra extract, but also Carnelian sinensis extract and Chamomilla extract.
[0067] In a particular embodiment, the composition as defined above, comprises a further compound selected from the group consisting of Pyrroloquinoline quinone disodium, Zinc bisglycinate (30 % zinc), L- Hydroxyproline, L- Phenylalanine, L- Isoleucine, hyaluronic acid, Pyridoxine hydrocloride (82.82% vitamin B6), L-ascorbic acid (82.64% vitamin C), Magnesium bisglycinate (20% magnesium), Melissa officinalis extract, Passiflora incarnata extract (5% flavonoids), and mixtures thereof.
[0068] In another particular embodiment, the composition as defined above comprises a further autophagy-inducing / detoxifying compound selected from the group consisting of Pyrroloquinoline quinone disodium and Zinc bisglycinate (30 % zinc).
[0069] In another particular embodiment, the composition as defined above comprises a further compound capable of repairing and regenerating cellular structures, wherein the compound is selected from the group consisting of L- Hydroxyproline, L- Phenylalanine, L-Isoleucine, Hyaluronic acid, Pyridoxine hydrochloride (82.82% vitamin B6) L-ascorbic acid (82.64% vitamin C), Magnesium bisglycinate (20% magnesium), and mixtures thereof.In another particular embodiment, the composition as defined above comprises a further compound capable of promoting sleep, where the compound is selected from the group consisting of Melissa officinalis extract and Passiflora incarnata extract (5% flavonoids).
[0070] The Melissa officinalis extract, commonly known as Lemon Balm extract, is presented as fine powder ranging in color from greenish or yellow-brown to dark brown. It is obtained from the dried leaves and occasionally stems of the plant. The most common extraction solvents are hydroalcoholic solutions (water and ethanol mixtures) or hot water, chosen to efficiently extract polar phenolic compounds. The extract generally exhibits good solubility in water and hydroalcoholic solutions, although solubility might decrease with very high ethanol concentrations used during extraction. This extract is standardized in apigenin. Particle size is controlled, often falling within the 60-100 mesh range for powdered extracts. As per common industry standards for natural products, this extract is preferably specified as GMO-free and non-irradiated.
[0071] The Passiflora incarnata extract, derived from Passionflower, is characteristically a fine powder, with colours ranging from greenish-yellow to brown or greenish-brown. It is obtained from the dried aerial parts (leaves, stems, sometimes flowers) of the plant.
[0072] Extraction is typically performed using hydroalcoholic solvents, most commonly ethanol-water mixtures (e.g., ethanol 40-70% v / v), as these effectively extract the target flavonoid constituents. This extract is standardized to its total flavonoid content with common specifications requiring a minimum content (e.g., 0.5% to 5% or higher), determined by UV spectrophotometry or HPLC. The extract exhibits partial solubility in water but better solubility in hydroalcoholic mixtures and ethanol, consistent with the nature of flavonoids. Particle size for powdered forms is typically controlled, commonly within the 60-100 mesh range. It is standard practice to prefer material specified as GMO-free and non-irradiated.
[0073] In another particular embodiment, the composition as defined above comprises:
[0074] Pleurotus ostreatus extract, Chlorella extract selected from Chlorella vulgaris and Chlorella pyrenoidosa extract, L- Arginine, L- Alanine, and Melatonin. In another particular embodiment, the composition as defined above comprises: Pleurotus ostreatus extract, Chlorella vulgaris algae extract, L- Arginine, L- Alanine, and Melatonin.
[0075] In another particular embodiment, the composition as defined above comprises:
[0076] Pleurotus ostreatus extract, Chlorella extract selected from Chlorella vulgaris and Chlorella pyrenoidosa extract, L- Arginine, L- Alanine, and Schisandra extract.
[0077] In another particular embodiment, the composition as defined above comprises:Pleurotus ostreatus extract, Chlorella extract selected from Chlorella vulgaris and Chlorella pyrenoidosa extract, L- Arginine, L- Alanine, L-Serine, L-Lysine, and Schisandra extract.
[0078] In another particular embodiment, the composition as defined above comprises: Pleurotus ostreatus extract, Chlorella extract selected from Chlorella vulgaris and Chlorella pyrenoidosa extract, L- Arginine, L- Alanine, L-Serine, L-Lysine, Melatonin, Schisandra extract, and green tea extract.
[0079] In a particular embodiment, the composition as defined above is that where the natural extract A is in an amount from 5 to 150 mg. In another particular embodiment, the composition as defined above is that where the natural extract A is in an amount from 20 mg to 130 mg. In another particular embodiment, the composition as defined above is that where the natural extract A is in an amount from 50 mg to 125 mg. In another particular embodiment, the composition as defined above is that where the natural extract A is in an amount from 70 mg to 115 mg. In another particular embodiment, the composition as defined above is that where the natural extract A is in an amount from 90 mg to 105 mg.
[0080] In another particular embodiment, the composition as defined above is that where: the at least an amino acid is in an amount from 2 to 600 mg. In another particular embodiment, the composition as defined above is that where the at least an amino acid is in an amount from 10 mg to 550 mg. In another particular embodiment, the composition as defined above is that where the at least an amino acid is in an amount from 30 mg to 500 mg. In another particular embodiment, the composition as defined above is that where the at least an amino acid is in an amount from 60 mg to 450 mg. In another particular embodiment, the composition as defined above is that where the at least an amino acid is in an amount from 80 mg to 400 mg. In another particular embodiment, the composition as defined above is that where the at least an amino acid is in an amount from 100 mg to 350 mg. In another particular embodiment, the composition as defined above is that where the at least an amino acid is in an amount from 160 mg to 330 mg. In another particular embodiment, the composition as defined above is that where the at least an amino acid is in an amount from 210 mg to 300 mg. In another particular embodiment, the composition as defined above is that where the at least an amino acid is in an amount from 260 mg to 280 mg. In another particular embodiment, the composition as defined above is that where the at least an amino acid is in an amount of 270 mg. The following concentrations of amino acids, which are essential building blocks for keratin and collagen synthesis, are especially appropriate to support the regeneration and structural integrity of the hair shaft and follicular environment.The following concentrations of plant extract B, characterized by its adaptogenic stressresponse modulation and promotion of restful sleep, are considered appropriate to mitigate stress-induced perturbations of the hair growth cycle, support the body’s natural restorative processes, and / or alleviate scalp tension, without compromising formulation stability or safety.
[0081] In another particular embodiment, the composition as defined above is that where melatonin is in an amount from 0.5 to 3 mg and the plant extract B is in an amount from 20 to 200 mg.
[0082] In another particular embodiment, the composition as defined above is that where the melatonin is in an amount from 0.5 to 2 mg. In another particular embodiment, the composition as defined above is that where the melatonin is in an amount from 0.5 to 1.5 mg. In another particular embodiment, the composition as defined above is that where the melatonin is in an amount of 1 mg.
[0083] In another particular embodiment, the composition as defined above is that where the plant extract B specifically, Schisandra extract, is in an amount from 40 mg to 180 mg. In another particular embodiment, the composition as defined above is that where the plant extract B specifically, Schisandra extract is in an amount from 60 mg to 160 mg. In another particular embodiment, the composition as defined above is that where the plant extract B specifically, Schisandra extract is in an amount from 75 mg to 145 mg. In another particular embodiment, the composition as defined above is that where the plant extract B specifically, Schisandra extract is in an amount from 85 mg to 125 mg. In another particular embodiment, the composition as defined above is that where the plant extract B specifically, Schisandra extract is in an amount from 85 mg to 110 mg. In another particular embodiment, the composition as defined above is that where the plant extract B specifically, Schisandra extract is in an amount of 100 mg
[0084] The relative proportions of natural extract A, the selected amino acids, and plant extract B, specifically, Schisandra extract, may be deliberately modulated across a broad spectrum to optimise stability, sensory qualities and / or biological performance. Accordingly, the invention encompasses multiple embodiments in which these constituents are present at different weight ratios.
[0085] To enhance formulation performance, such as solubility, stability, palatability and targeted delivery, the composition may further include pharmaceutically acceptable excipients and, where desired, advanced carrier systems.Thus, in a particular embodiment, the composition as defined above further comprises excipients selected from the group consisting of surfactants, cosolvents, taste-masking agents, diluents, and mixtures thereof, and, optionally, carriers selected from the group consisting of liposomes, microparticles, micelles, cyclodextrins, phospholipid complexes, solid lipid microparticles, solid lipid microparticles, microstructured lipid carriers, selfemulsifying drug delivery systems, microemulsions, hydrophilic polymers, biodegradable polymers, surfactant-stabilized emulsions, phytosomes, microsuspensions, colloidal dispersions, and mixtures thereof.
[0086] Postbiotics, which are a preparation of inanimate microorganisms and / or their components that confer a health benefit on the host, play a significant role in enhancing scalp health and promoting hair growth. Postbiotics help maintain a balanced scalp microbiome, reduce inflammation, and support the natural hair growth cycle. In a particular embodiment, the oral composition as defined above, further comprises postbiotics.
[0087] In another particular embodiment, the composition as defined above, is that where the postbiotics, when are present, are in an amount equal to or less than 50 mg. In another particular embodiment, the oral composition as defined above, is that where the postbiotics, when are present, are in an amount equal to or less than 40 mg. In another particular embodiment, the oral composition as defined above, where the postbiotics, when are present, are in an amount equal to or less than 30 mg. In another particular embodiment, the oral composition as defined above, is that where the postbiotics, when are present, are in an amount equal to or less than 20 mg. In another particular embodiment, the oral composition as defined above, is that where the postbiotics, when are present, are in an amount equal to or less than 10 mg. In another particular embodiment, the oral composition as defined above, is that where the postbiotics, when are present, are in an amount equal to or less than 5 mg.
[0088] Examples of appropriate postbiotics are Lactobacillus plantarum tyndallized, Lactobacillus paracasei tyndallized, Lactobacillus reuteri tyndallized, Lactobacillus acidophilus tyndallized, Bifidobacterium longum tyndallized, and Bifidobacterium lactis tyndallized.
[0089] In a particular embodiment, the oral composition as defined above, is that where the postbiotics are selected from the group consisting of Lactobacillus plantarum tyndallized, Lactobacillus paracasei tyndallized, Lactobacillus reuteri tyndallized, Lactobacillus acidophilus tyndallized, Bifidobacterium longum tyndallized, Bifidobacterium lactis tyndallized, and mixtures thereof.In a particular embodiment, the composition as defined above comprising additional components selected from the group consisting of vitamins different to the ones provided above, amino acids different to the ones provided above, minerals different to the ones provided above, proteins, carbohydrates, prebiotics, probiotics, herbal extracts, fats, flavorings, sweeteners, antioxidants, and a mixture thereof. Example of such appropriate vitamins are, Vitamin E, Biotin, Vitamin D3, Niacinamide (Vitamin B3), Calcium Pantothenate (Vitamin B5),), Folic Acid (Vitamin B9), Cyanocobalamin (Vitamin B12). Examples of such appropriate amino acids are Aspartic acid, Valine, Threonine, Histidine, Phenylalanine, Cysteine, and Glutamine. Examples of such appropriate minerals are, iron, selenium, copper, calcium, manganese, potassium, silicon, chromium, iodine, phosphorus, molybdenum, sulfur, and sodium.
[0090] Examples of appropriate carbohydrates are fructose, glucose, maltodextrin, inulin, betaglucan, xylitol, D-ribose, arabinogalactan, isomaltulose, pectin, oligofructose, trehalose, starch, cyclodextrin, galactooligosaccharides (GOS), polydextrose, sorbitol, erythritol, lactose, and mannitol.
[0091] Examples of appropriate proteins are hydrolyzed collagen, pea protein, rice protein, soy protein isolate, hemp proteincollagen peptides, silk protein, quinoa protein, oat protein, pumpkin seed protein, sunflower seed protein, almond protein, and fava bean protein.
[0092] Examples of appropriate fats are sucrose esters of fatty acids, omega-3 fatty acids (EPA and DHA), omega-6 fatty acids (linoleic acid), omega-9 fatty acids (oleic acid), mediumchain triglycerides (MCTs), evening primrose oil, borage oil, flaxseed oil, chia seed oil, coconut oil, avocado oil, walnut oil, pumpkin seed oil, hemp seed oil, black currant seed oil, conjugated linoleic acid (CLA), phospholipids (such as phosphatidylcholine), lecithin, and fish oil.
[0093] Examples of appropriate flavorings are natural vanilla extract, natural strawberry flavor, natural blueberry flavor, natural raspberry flavor, natural lemon flavor, natural orange flavor, natural mint flavor, natural cherry flavor, natural peach flavor, natural apple flavor, natural pineapple flavor, natural mango flavor, natural grape flavor, natural watermelon flavor, natural coconut flavor, natural cinnamon flavor, natural chocolate flavor, natural caramel flavor, and natural almond flavor.
[0094] Examples of appropriate antioxidants are Turmeric, Resveratrol, Astaxanthin, Licorice (Glycyrrhiza glabra), quercetin, coenzyme Q10, alpha-lipoic acid, selenium, N-acetylcysteine, grape seed extract, lutein, zeaxanthin, beta-carotene, lycopene, pycnogenol (pine bark extract), curcumin, glutathione, rosemary extract, pomegranateextract, olive leaf extract, and tocotrienols.
[0095] These botanical extracts are known for their anti-inflammatory, antioxidant, or healthpromoting properties. However, their efficacy in traditional solid oral dosage forms is hampered by their limited solubility and subsequent poor absorption in the gastrointestinal tract. By providing these active ingredients in a liquid oral composition, the invention significantly enhances the solubility and absorption of the active ingredients in the gastrointestinal tract. This improvement leads to higher and more consistent plasma concentrations, resulting in better efficacy in reducing hair loss and promoting hair growth as a complementary therapy to pharmacological treatments and more predictable pharmacokinetic profiles.
[0096] The compositions of the present invention may comprise a broad spectrum of excipients such as surfactants, cosolvents, taste-masking agents, diluents to adjust the concentration and viscosity of the formulation, ensuring ease of administration and consistent dosing.
[0097] Appropriate surfactants may be non-ionic surfactants, ionic surfactants, and amphoteric surfactants.
[0098] Examples of appropriate non-ionic surfactants are: Polysorbates (e.g., Polysorbate 20, Polysorbate 40, Polysorbate 60, Polysorbate 80), Polyoxyl 35 castor oil, Polyoxyl 40 hydrogenated castor oil (Cremophor EL), Sorbitan esters (e.g., Sorbitan monolaurate, Sorbitan monooleate, Sorbitan monopalmitate), Polyethylene glycol (PEG) esters, Sucroesters, Poloxamers (e.g., Poloxamer 188, Poloxamer 407), and Lauryl macrogolglycerides.
[0099] Examples of appropriate ionic surfactants are Sodium lauryl sulfate (SLS), Sodium dodecyl sulfate (SDS), Sodium stearate, Sodium oleate, Sodium cetostearyl sulfate, and Sodium caprylate.
[0100] Examples of appropriate amphoteric surfactants are Cocamidopropyl betaine, Cocamphocarboxyglycinate, Cocamidopropyl hydroxysultaine, Lauryl betaine, and Lauryl dimethylamine oxide.
[0101] Examples of appropriate cosolvents are Glycerol, Propylene glicol, Polyethylene glycol (PEG) 400, PEG 600, Diethylene glycol monoethyl ether (Transcutol), Isopropanol, 1,2-Propylene glycol, Polyethylene glycol (PEG) 2000, PEG 3350, PEG 6000, Caprylic / capric triglyceride (MCT oil), N-Methyl-2-pyrrolidone (NMP).Examples of appropriate taste-masking agents are natural sweeteners (e.g., stevia, monk fruit extract, licorice root extract), artificial sweeteners (e.g., sucralose, aspartame, saccharin, acesulfame potassium), sugar alcohols (e.g., xylitol, sorbitol, maltitol, erythritol), flavors (e.g., fruit flavors like cherry, orange, lemon; mint; vanilla; chocolate), essential oils (e.g., peppermint oil, lemon oil), acidulants (e.g., citric acid, malic acid, tartaric acid), salts (e.g., sodium chloride, potassium chloride), masking agents (e.g., cyclodextrins, tannins), aromatic compounds (e.g., vanillin, ethyl vanillin, menthol), or texturizers (e.g., glycerin, xanthan gum).
[0102] Examples of appropriate diluents include water or aqueous solutions. Thus, in a particular embodiment, the oral composition as defined above is a liquid oral composition comprising water as diluent.
[0103] The extracts of the oral liquid composition of the present invention may be used in encapsulated form. The inclusion of carriers such as liposomes, microparticles, or micelles serves to encapsulate such extracts, facilitating enhanced absorption and bioavailability.
[0104] Examples of appropriate carriers are liposomes, microparticles, micelles, cyclodextrins, phospholipid complexes, solid lipid microparticles, solid lipid microparticles, microstructured lipid carriers, self-emulsifying drug delivery systems (SEDDS), microemulsions, hydrophilic polymers, biodegradable polymers, surfactant-stabilized emulsions, phytosomes, microsuspensions, and colloidal dispersions.
[0105] The liposomes according to the present invention are phospholipid-based carriers.
[0106] Examples of appropriate cyclodextrins are as p-cyclodextrin, hydroxypropyl-p-cyclodextrin, and methyl-p-cyclodextrin. They form inclusion complexes with active ingredients to enhance solubility.
[0107] Appropriate phospholipid complexes can be those that use phospholipids such as phosphatidylcholine to enhance the bioavailability of the extracts.
[0108] Examples of appropriate hydrophilic polymers are hydroxypropyl methylcellulose (HPMC), polyvinylpyrrolidone (PVP), and are used to increase the viscosity and stability of the formulation.
[0109] Examples of appropriate biodegradable polymers are polylactic acid (PLA), polyglycolicacid (PGA), poly(lactic-co-glycolic acid) (PLGA), used for controlled release.
[0110] Additionally, the use of taste-masking agents ensures that the formulation is palatable, thus improving patient compliance.
[0111] Accordingly, the combination of further ingredients of the composition of the present invention results especially useful for the intended uses. Thus, it is also part of the present invention the use of the oral composition as defined above, for improving brightness, hydration, elasticity, firmness, and / or hair shine. Particularly, this use comprises administering an effective amount of the oral composition for providing improved brightness, hydration, elasticity, firmness, and / or hair shine.
[0112] As mentioned above, it is an aspect of the present invention the use of a composition as defined above, promoting natural hair growth; the prevention and / or reduction of natural hair loss; promoting hair health; or any combination thereof.
[0113] The composition of the present invention has an antioxidant effect. This aspect may be also formulated as a method for preventing hair loss, specifically, natural hair loss, promoting hair health, promoting hair growth, specifically natural hair growth, or any combination thereof, which comprises administering an effective amount for the intended uses to a subject in need thereof. This aspect of the invention is considered non-therapeutic.
[0114] In a particular embodiment of the use of the composition for promoting hair growth, specifically, natural hair growth promoting hair health, the prevention and / or reduction of hair loss, specifically, natural hair loss, or any combination thereof is mediated through regeneration of hair follicles.
[0115] Building on its standalone benefits in preventing and / or reducing natural hair loss and promoting hair growth, the composition may also be employed to augment and / or complement existing drug-based therapies, enhancing efficacy, or addressing residual scalp and follicular issues not fully resolved by pharmacological agents alone.
[0116] In a particular embodiment, the use of the composition as defined above is that where the composition is used as a complementary treatment to pharmacological treatments.
[0117] This composition may be used in a subject whose hair loss is caused by a condition selected from androgenetic alopecia, alopecia areata, alopecia mucinosa, telogen effluvium, chronic inflammation, extreme and / or chronic stress, hair treatments, hereditarydisorders, hormonal changes, malnutrition, aging and trichotillomania. The treatment of hair loss caused by a condition as those mentioned or by a side -effect of a therapy comprises administering an effective amount of the composition for the treatment in a subject in need thereof. Correspondingly, a composition according to the present invention for use in promoting hair growth in subjects suffering from such conditions, and / or for use in preventing and / or treating hair loss caused by a condition from those mentioned above, is considered part of the invention, for instance, wherein the composition is administered together with a pharmacological treatment. The pharmacological treatment includes administering a drug such as finasteride, minoxidil, or dutasteride.
[0118] It is considered part of the invention, a composition as defined above in combination with a pharmacological treatment, for use in the prevention of hair loss, in promoting hair growth, or any combination thereof.
[0119] In a particular embodiment, the composition for use as defined above is that where promoting hair growth, the prevention and / or reduction of hair loss, or any combination thereof is mediated through regeneration of hair follicles.
[0120] In another particular embodiment, the composition for use as defined above is that where the composition is administered once a day.
[0121] In another particular embodiment, the composition for use as defined above is that where the composition is administered between 30 to 60 minutes before going to sleep at nighttime.
[0122] In another particular embodiment, the composition for use as defined above is that where the composition is administered at nighttime in a regimen which further comprises administering a second composition for promoting hair growth and / or reducing hair loss in daytime.
[0123] When the prevention and / or treatment is referred to therapeutic use, the composition is to be applied to a subject suffering from hair loss caused by any of the conditions mentioned above.
[0124] The composition can also be used for improving hair brightness, hydration, elasticity, firmness, and shine.
[0125] To accommodate both patient convenience and circadian biology, the composition may bedelivered according to various timing regimens.
[0126] In a particular embodiment, the use of the composition as defined above is that where the composition is administered once a day.
[0127] In another particular embodiment, the use of the composition as defined above is that where the composition is administered between 30 to 60 minutes before going to sleep at nighttime.
[0128] To harness the scalp’s inherent nighttime restorative processes in conjunction with active daytime support, the composition can be dosed at night while a complementary hairgrowth formulation is administered during daytime.
[0129] Thus, in a particular embodiment, the use of the composition as defined above is that where the composition is administered at nighttime in a regimen which further comprises administering a second composition for promoting hair growth and / or reducing hair loss in daytime.
[0130] In another particular embodiment, the use as defined above is that where the second composition comprises an extract selected from the group consisting of Epilobium parviflorum extract, Nigella sativa L. extract, Boswellia serrata extract, and mixtures thereof.
[0131] In particular, the Epilobium parviflorum extract is a dry extract presented as a brown powder. The part of the plant used for this extract is the herb. The solvents employed in the extraction process are generally water and alcohol. The extract is partially soluble, with an extraction ratio generally around 10:1. It contains polyphenols in a concentration of at least 5%. The particle size of the extract generally is around 80 mesh. In a particular embodiment, the purity parameters include a total ash content of not more than 10% and a loss on drying of not more than 5%. The relative density of the extract generally ranges from 40 to 60 grams per 100 milliliters. Additionally, the extract is generally GMO-free and has not been irradiated.
[0132] The Nigella sativa L. extract is presented as a brown-yellow powder. The part of the plant used for this extract is the seeds. Maltodextrin is generally present. Generally, the extraction solvent used is water. The extract is partially soluble, with an extraction ratio generally of 4:1. The relative density of the extract generally ranges from 40 to 60 grams per 100 milliliters, and the particle size is generally around 80 mesh. The loss on drying is not more than 5%. Additionally, the extract is generally GMO-free and non-irradiated.The Boswellia serrata extract is an oleoresin with low solubility. It is characterized by its brown color and turbid dilution in water. The part of the plant used for this extract is the oleoresin from the tree. The extract is standardized to contain a minimum of 12% total boswellic acids and is partially soluble. Additionally, the extract is generally GMO-free and has not been irradiated.
[0133] In another particular embodiment, the use of as defined above is that where the second composition comprises an extract selected from the group consisting of Saw palmetto extract (Serenoa repens, fruit), Pygeum extract (Prunus africana, bark), Ashwagandha extract (Withania somnifera, root). This second composition may further comprise Collagen precursor amino acids (L-glycine, L-proline, L-hydroxyproline, L-alanine, L-serine, L-leucine, L-phenylalanine, L-isoleucine, L-arginine, L-glutamine, L-glutamic acid, L-ornithine); Keratin precursor amino acids (L-carnitine, L-arginine, L-alanine, L-glutamine, L-glutamic acid, L-lysine, L-glycine, L-tyrosine, L-leucine, L-serine, L-ornithine), L-cysteine, L-methionine and Turmeric extract (Curcuma longa, rhizome) and mixtures thereof.
[0134] In another particular embodiment, the use as defined above is that where the second composition comprises an extract selected from the group consisting of Saw palmetto extract (Serenoa repens, fruit), Blueberry extract, >5% anthocyanidins (Vaccinium myrtillus, fruit), Polygonum cuspidatum extract (>95 % resveratrol); Haematococcus pluvialis extract (astaxanthin). This second composition may comprise Collagen precursor amino acids (L-glycine, L-proline, L-hydroxyproline, L-alanine, L-serine, L-leucine, L-phenylalanine, L-isoleucine, L-arginine, L-glutamine, L-glutamic acid, or L-ornithine); Keratin precursor amino acids (L-carnitine, L-arginine, L-alanine, L-glutamine, L-glutamic acid, L-lysine, L-glycine, L-tyrosine, L-leucine, L-serine, or L-ornithine), L-cysteine, L-methionine, Turmeric extract (Curcuma longa, rhizome), or mixtures thereof.
[0135] The Serenoa repens (Saw Palmetto) extract may presented as a lipophilic (oily) paste or powder, ranging in colour from yellowish-brown to dark brown, derived from the dried ripe fruits (berries) of the plant. Extraction utilizes lipophilic solvents such as hexane or supercritical CO2 to isolate the fatty acids and sterols effectively. Consequently, this extract exhibits poor solubility in water but is soluble in oils and nonpolar organic solvents. It is specifically standardized to contain a high percentage of total fatty acids, typically ranging from 80% to 95% by weight, often quantified via Gas Chromatography (GC). Besides fatty acids, it characteristically contains phytosterols like beta-sitosterol. The extract is preferably specified as GMO-free and non-irradiated.The Blueberry extract, derived from species such as Vaccinium myrtillus (Bilberry), is characteristically prepared as a dark violet, purple, or reddish-brown powder obtained from the dried fruits. Extraction is typically carried out using water, ethanol, or aqueous ethanol solutions, which are effective for isolating water-soluble polyphenols. This extract is standardized based on its anthocyanin content (specifically anthocyanidins glycosides), commonly ranging from 10% to 25% or higher by weight, usually quantified by HPLC or UV-Vis spectrophotometry. It generally exhibits good to partial solubility in water. In addition to anthocyanins, it contains other flavonoids and phenolic acids native to the fruit. Particle size is commonly controlled, often within the 60-100 mesh range. This extract is preferably specified as GMO-free and non-irradiated.
[0136] The Polygonum cuspidatum (Japanese Knotweed) extract is typically presented as an off-white, yellowish, or light brown to brown powder, derived primarily from the dried roots and / or rhizomes of the plant. Common extraction solvents include ethanol or aqueous ethanol mixtures, chosen for their efficiency in isolating stilbenoids. This extract is specifically standardized based on its resveratrol content, with concentrations varying widely depending on the grade (e.g., 20%, 50%, up to 98% or higher by weight), typically quantified via High-Performance Liquid Chromatography (HPLC). It exhibits poor solubility in water but demonstrates good solubility in ethanol and other organic solvents like DMSO or acetone. Particle size is generally controlled, often within the 60-100 mesh range. The material is preferably specified as being GMO-free and has not been subjected to irradiation.
[0137] The Haematococcus pluvialis extract is presented either as a dark red, viscous oleoresin or as a reddish to reddish-brown powder (often through microencapsulation or drying), derived from the whole dried biomass of the microalga, typically cultivated under stress conditions to maximize astaxanthin production. Extraction is commonly performed using supercritical CO2 or organic solvents (e.g., hexane, acetone) effective for isolating lipid-soluble carotenoids. This extract is specifically standardized to contain a defined concentration of astaxanthin, typically ranging from 1% to 10% by weight depending on the product form (oleoresin vs. powder), usually quantified via HPLC or UV-Vis spectrophotometry. As a lipophilic carotenoid, astaxanthin renders the extract practically insoluble in water but soluble in oils, fats, and some organic solvents. The extract is typically produced as GMO-free and non-irradiated.
[0138] The Curcuma longa (Turmeric) extract is characteristically a bright yellow to orange-yellow powder obtained from the dried rhizomes of the plant. Extraction is performed using organic solvents such as ethanol, ethyl acetate, or acetone, effective for isolating the main bioactive compounds. This extract is specifically standardized to contain a highconcentration of total curcuminoids (the complex including curcumin, demethoxycurcumin, and bisdemethoxycurcumin), commonly 1-40% by weight, typically quantified via HPLC or UV-Vis spectrophotometry. Curcuminoids exhibit poor solubility in water but are soluble in organic solvents like ethanol, DMSO, and acetone. The particle size is commonly controlled to fall within the 60-100 mesh range. This extract is preferably specified as GMO-free and non-irradiated.
[0139] To simplify and streamline the coordinated day-and-night treatment regimen, the invention further provides a comprehensive kit for promoting hair growth, promoting hair health, the prevention and / or reduction of hair loss.
[0140] Hence, it is part of the present invention a kit for promoting hair growth, promoting hair health, the prevention and / or reduction of hair loss, or any combination thereof comprising:
[0141] a) a composition as defined above for nighttime administration,
[0142] b) a composition for promoting hair growth and reducing hair loss for daytime administration; and
[0143] c) instructions for the administration of the compositions.
[0144] Throughout the description and claims the word "comprise" and variations of the word, are not intended to exclude other technical features, additives, components, or steps.
[0145] Furthermore, the word “comprise” encompasses the case of “consisting of”. Additional objects, advantages and features of the invention will become apparent to those skilled in the art upon examination of the description or may be learned by practice of the invention. The following examples and drawings are provided by way of illustration, and they are not intended to be limiting of the present invention. Reference signs related to drawings and placed in parentheses in a claim, are solely for attempting to increase the intelligibility of the claim and shall not be construed as limiting the scope of the claim. Furthermore, the present invention covers all possible combinations of particular and preferred embodiments described herein.
[0146] For reasons of completeness, various aspects of the invention are set out in the following numbered clauses:
[0147] 1. A composition for promoting hair growth, promoting hair health, the prevention and / or reduction of hair loss, or any combination thereof, comprising:
[0148] a) at least a natural extract A selected from the group consisting of Pleurotus ostreatus extract, Chlorella extract selected from Chlorella vulgaris and Chlorella pyrenoidosa extract, Silybum marianum extract;b) at least an amino acid selected from the group consisting of L- Arginine, L- Alanine, L-Glycine, L- Serine, L- Lysine, L- Leucine, and L- Proline; and
[0149] c) melatonin; at least a plant extract B selected from the group consisting of, Schisandra extract, Camellia sinensis extract, and Chamomilla extract; or a combination thereof.
[0150] 2. The composition according to clause 1 which is an oral composition.
[0151] 3. The oral composition according to any of the clauses 1-2, which is a liquid oral composition.
[0152] 4. The composition according to any of the clauses 1-3 wherein:
[0153] a) the at least natural extract A is selected from the group consisting of Pleurotus ostreatus extract, and Chlorella extract selected from Chlorella vulgaris and Chlorella pyrenoidosa extract;
[0154] b) the at least an amino acid is selected from the group consisting of L- Arginine, L-Alanine, L-Glycine, L- Serine, and L- Lysine; and
[0155] c) melatonin; the at least a plant extract B selected from the group consisting of, Schisandra extract, and green tea extract; or a combination thereof.
[0156] 5. The composition according to clause 4 comprising:
[0157] a) Pleurotus ostreatus extract;
[0158] b) the at least an amino acid is selected from the group consisting of L- Arginine, and L-Alanine; and
[0159] c) Schisandra extract or Melatonin.
[0160] 6. The composition according to any of the clauses 1-5, comprises a further compound selected from the group consisting of L- Arginine, L- Alanine, L-Glycine, L- Serine, L-Lysine, L- Leucine, L- Proline, Pyrroloquinoline quinone disodium, Zinc bisglycinate, L-Hydroxyproline, L- Phenylalanine, L- Isoleucine, Hyaluronic acid, Pyridoxine hydrocloride, L-ascorbic acid, Magnesium bisglycinate, Melissa officinalis extract, Passiflora incarnata extract, and mixtures thereof.
[0161] 7. The composition according to any of the clauses 1-6, wherein natural extract A is in an amount from 5 to 150 mg.
[0162] 8. The composition according to any of the clauses 1-6, wherein the at least an amino acid is in an amount from 2 to 600 mg.
[0163] 9. The composition according to any of the clauses 1-6, wherein melatonin is in anamount from 0.5 to 3 mg and plant extract B is in an amount from 20 to 200 mg.
[0164] 10. Use of a composition as defined in any of the clauses 1-9, in the prevention of hair loss, in promoting hair health, in promoting hair growth, or any combination thereof.
[0165] 11. Use of the composition according to clause 10, wherein promoting hair growth, promoting hair health, the prevention and / or reduction of hair loss, or any combination thereof is mediated through regeneration of hair follicles.
[0166] 12. Use of the composition according to any of the clauses 10-11, wherein the composition is administered once a day.
[0167] 13. Use of the composition according to any of the clauses 10-12, wherein the composition is administered between 30 to 60 minutes before going to sleep at nighttime.
[0168] 14. Use of the composition according to any of the clauses 10-13, wherein the composition is administered at nighttime in a regimen which further comprises administering a second composition for promoting hair growth and / or reducing hair loss in daytime.
[0169] 15. A kit for promoting hair growth, promoting hair health, the prevention and / or reduction of hair loss; or any combination thereof comprising:
[0170] a) a composition as defined in any of the clauses 1-9 for nighttime administration, b) a composition for promoting hair growth and reducing hair loss for daytime administration; and
[0171] c) instructions for the administration of the compositions.
[0172] Examples
[0173] Example 1. Preparation of an oral composition of Pleurotus ostreatus extract, L- Arginine, and Schisandra extract
[0174] In a 100 ml round bottom flask, 10 mg of Pleurotus ostreatus extract, 60.45 mg of L-Arginine and 50.00 mg Schisandra extract were added in 18 ml of H2O. The mixture was stirred until complete homogenization at room temperature.
[0175] Example 2. Preparation of an oral composition of Pleurotus ostreatus extract, L- Arginine, L- Alanine, and Schisandra extractIn a 100 ml round bottom flask, 10.00 mg of Pleurotus ostreatus extract, 60.45 mg of L-Arginine, 32.75 mg of L- Alanine, and 50.00 mg Schisandra extract were added in 18 ml of H2O. The mixture was stirred until complete homogenization at room temperature.
[0176] Example 3. Preparation of an oral composition of Pleurotus ostreatus extract, L- Arginine, and Melatonin
[0177] In a 100 ml round bottom flask, 10.00 mg of Pleurotus ostreatus extract, 60.45 mg of L-Arginine and 1.00 mg Melatonin were added in 18 ml of H2O. The mixture was stirred until complete homogenization at room temperature.
[0178] Example 4. Preparation of an oral composition of Pleurotus ostreatus extract, L- Glycine, and Melatonin
[0179] In a 100 ml round bottom flask, 10.00 mg of Pleurotus ostreatus extract, 85.00 mg of L-Glycine, and 1.00 mg Melatonin were added in 18 ml of H2O. The mixture was stirred until complete homogenization at room temperature.
[0180] Example 5. Preparation of an oral composition of Pleurotus ostreatus extract, L- Arginine, L- Alanine, and Schisandra extract
[0181] In a 100 ml round bottom flask, 10.00 mg of Pleurotus ostreatus extract, 60.45 mg of L-Arginine, 32.75 mg of L- Alanine, and 1.00 mg Schisandra extract were added in 18 ml of H2O. The mixture was stirred until complete homogenization at room temperature.
[0182] Example 6. Preparation of an oral composition of Chlorella vulgaris algae extract, L-Arginine, and Melatonin
[0183] In a 100 ml round bottom flask, 45,00 mg of Chlorella vulgaris algae extract, 60.45 mg of L-Arginine, and 1.00 mg Melatonin were added in 18 ml of H2O. The mixture was stirred until complete homogenization at room temperature.
[0184] Example 7. Preparation of an oral composition of Pleurotus ostreatus extract, L- Arginine, L- Alanine, and Schisandra extract with further ingredients
[0185] In a 100 ml round bottom flask, 10.00 mg of Pleurotus ostreatus extract, 45.00 mg of Chlorella pyrenoidosa algae extract (1% spermidine), 50.00 mg of Silybum marianum extract dry (30% sylbin), 2.00 mg of Pyrroloquinoline quinone disodium, 16.66 mg of Zinc bisglycinate (30 % zinc), 135.00 mg of L-Glycine, 50.25 mg of L-Proline, 44.75 mg of L-Hydroxyproline, 32.75 mg of L- Alanine, 62.25 mg of L-Serine, 10.25 mg of L-Leucine, 9.75 mg of L-Phenylalanine, 5.00 mg of L-lsoleucine, 60.45 mg of L-Arginine, 21.90 mg of L-Lysine, 17.58 mg of L-Tyrosine, 25.00 mg of Hyaluronic acid, 1.70 mg of Pyridoxine hydrocloride (82.82% vitamin B6), 19.36 mg of L-ascorbic acid (82.64% vitamin C), 282.00 mg of Magnesium bisglycinate (20% magnesium), 1.00 mg of Melatonin, 50.00 mg of Green tea extract (40% L-Theanine), 50.00 mg of Melissa officinalis extract, 150.00 mg of Passiflora incarnata extract, 50 mg of Chamomilla extract dry (1.2% apigenin), and 50 mg Schisandra extract were added in 18 ml of H2O and 3 ml of Glycerin, and 3 ml of grape fructose. The mixture was stirred until completed homogenization at room temperature.
[0186] The following compositions have been evaluated in examples 8,9, 10,11 and 12.
[0187] M1: A composition comprising Chlorella vulgaris extract, L-Arginine, and Melatonin in a ratio of 45:60:1 by weight.
[0188] M2: A composition comprising Pleurotus ostreatus extract, L-Arginine, and Melatonin in a ratio 10:60:1 by weight.
[0189] M3: A composition comprising Pleurotus ostreatus extract, L-Glycine and Melatonin in a ratio of 10:135:1 by weight.
[0190] Example 8. ORAC test of the present invention
[0191] Six technical replicates of each concentration assessed for M1, M2 and M3 were evaluated for antioxidant capacity by calculating the antioxidant potential by Oxygen Radical Absorbance Capacity (ORAC). Sample concentrations were specifically selected to cover a wide range of concentrations where the products could present antioxidant activity. Samples M1, M2 and M3 were diluted in medium. Based on this, two standard curves were performed using the different solvents. Samples and the antioxidant standard curve were added to the 96-well microtiter plate. Additionally, the Fluorescein Solution was added to each well and the plate was incubated at 37°C for 30 minutes. Finally, the Free Radical Initiator Solution was added to each well and immediately began reading the samples with the fluorescent microplate reader at 37°C, with an excitation wavelength of 480 nm and an emission wavelength of 520 nm. The measurements were taken every 5 minutes for 1 hour.Table 1. Antioxidant capacity of M1, M2, and M3 based on ORAC assay
[0192] Antioxidant capacity was evaluated using the ORAC (Oxygen Radical Absorbance Capacity) assay. Each formulation (M1, M2, M3) was tested at three concentrations, with six technical replicates per concentration.
[0193] Each cell represents one technical replicate (R1-R6) at a given dilution of the total sample (expressed as a percentage).
[0194] Results are expressed as relative antioxidant activity: '+' (low) to '++++' (very high).
[0195] Sample Concentration R1 R2 R3 R4 R5 R6 M1 10 % ++++ +++ ++ ++++ +++ ++ M1 1 % ++ ++ ++++ +++ +++ ++ M1 0,1 % +++ +++ ++++ ++ ++ ++++ M2 10 % +++ ++ ++ ++++ ++++ +++ M2 1 % +++ ++++ ++ ++ +++ ++ M2 0,1 % +++ +++ ++++ +++ +++ +++
[0196] M3 1 % +++ ++++ ++ +++ +++ ++
[0197] +++ ++ +++ ++ +++ +++
[0198]
[0199] M3 0,1 %
[0200] T o complement the semi-quantitative ORAC data shown in T able 1 , the antioxidant capacity of the claimed compositions was also determined quantitatively by the ORAC assay. In this experiment, antioxidant activity was expressed in Trolox Equivalents (pM TE), which provides a direct numerical measure of the ability of the compositions to scavenge peroxyl radicals. Three representative compositions falling within the scope of the amended claims, M1, M2 and M3, were tested at concentrations of 10%, 1% and 0.1%.
[0201] The antioxidant capacity of the claimed compositions was evaluated by the ORAC assay, which measures the ability of a sample to scavenge peroxyl radicals. Results are expressed in Trolox Equivalents (pM TE). Three compositions falling within the scope of the amended claims (M1, M2, and M3) were tested at concentrations of 10%, 1%, and 0.1%. The results are summarised in Table 2:
[0202] Table 2. Antioxidant ca pacity of M1, M2, and M3 based on ORAC assay Composition 10% (pM TE) 1%(pM TE) 0.1% (pM TE) M1 -107.0 122.0 (highest) -48.0 M2 -140.0 143.9 (highest) -52.0
[0203]
[0204] M3 143.0 (highest) -125.0 -55.0
[0205]
[0206] All three compositions demonstrate substantial radical scavenging activity across the tested concentration range, with ORAC values reaching up to 143.9 pM TE (M2 at 1%) and 143.0 pM TE (M3 at 10%). The consistent antioxidant performance across three distinct compositions within the claim scope confirms that the radical scavenging activity is a robust property of the claimed genus, not an isolated result for a single embodiment.
[0207] Example 9. Cell proliferation test of the present invention
[0208] Cell numbers and viability were determined using Trypan-Blue staining and counting in a Burker chamber under the microscope. For the MTT viability assay, human follicular dermal papilla cells (HFDPCs) were cultured overnight at a 10.000 cells / well density in a 96 well plate, in supplemented growth medium. 24 h later, the culture medium was replaced with fresh medium containing 0.5 % FBS in the presence of M1, M2, and M3 separately at different concentrations. In parallel, cells were cultured with EGF 20 ng / ml as a positive control for cell proliferation induction.
[0209] After 48 h of incubation, the medium was removed, and MTT solution was added to each well. Plates were incubated at 37°C for 3 h. MTT reagent was removed and DMSO at 100 % was added to each well to solubilize formazan crystals, then the absorbance was measured at 550 nm and 620 nm as a reference on a scanning multi-well spectrophotometer.
[0210] The preliminary results from the cell proliferation assay show that compositions M1, M2, and M3 promote a proliferative effect on HFDPC (from low-moderate to high), indicating hair growth effect.
[0211] Example 10. Cell proliferation test of composition M1
[0212] The effect of composition M1 on cell proliferation was evaluated in Human Follicle Dermal Papilla Cells (HFDPC), using Epidermal Growth Factor (EGF) as a positive control. Cell viability was assessed after 48 hours of treatment at concentrations ranging from 0.0001% to 0.1%. The results are summarised in Table 3:
[0213] Table 3. HFDPC proliferation results for composition M1. **** denotes p < 0.0001; n.s. = not statistically significant
[0214] Treatment Cell Viability Increase Significance
[0215] Control (C) Baseline —
[0216]
[0217] EGF (positive control) 53.7 ± 2.9% ****
[0218] M1 at 0.03% 15.6 ± 2.9% ****
[0219] M1 at 0.1% 24.6 ± 2.9% ****
[0220]
[0221] Composition M1 induced a statistically significant increase (p < 0.0001) in HFDPC viability at 0.03% (+15.6 ± 2.9%) and 0.1% (+24.6 ± 2.9%). Notably, lower concentrations (0.0001-0.01%) did not elicit a significant proliferative response, confirming a clear threshold effect consistent with a specific biological interaction rather than a non-specific nutritive or cytotoxic phenomenon.
[0222] Example 11. Philpott test of the present invention
[0223] Human hair follicles were isolated by manual extraction from the human nape. Hair follicles in the anagen phase were selected through morphologic discrimination and maintained in growth medium with Fungizone, penicillin and streptomycin supplements. Follicles were maintained free-floating in individual wells of 24-well plates, at 37°C in an atmosphere of 5 % CO2 / 95 % air. Basal images (Oh) were taken immediately after isolation using a stereomicroscope.
[0224] Tested samples at different concentrations, negative control and positive control (EGF, Epidermal Growth Factor, 20 ng / ml) were added to each well and plates were incubated at 37°C for 7 days. Images were taken after 7 days of treatment, under identical conditions. Finally, data analysis was performed using Imaged software.
[0225] The preliminary results from the Philpott test indicate that compositions M1, M2, and M3 stimulated hair growth, evidenced by an increase in hair fiber length after 7 days, as observed in microscopic images.
[0226] Example 12. Assay of antioxidant capacity in hair follicle cells of the present invention
[0227] The cells were cultured overnight at a 10.000 cells / well density in a black 96-well plate, in growth media. 24 h later, the culture media was removed and replaced by new culture medium supplied with M1, M2 and M3 compositions. Negative control and vitamin C (as positive control) were used for reference. After additional 24 h of incubation, PBS (Phosphate-Buffered Saline) and ROS (Reactive Oxygen Species) master mix were added in all cultured wells. 2 hours after ROS master mix addition to cells, ROS levels were measured in all samples. The intracellular ROS react with a fluorogenic sensorlocalized in the cytoplasm, resulting in a fluorescent product whose appearance is proportional to ROS levels. Fluorescence quantification was measured at Aex =490 / Aem =525.
[0228] In parallel, cell viability was quantified through MTT assay to normalize ROS levels to the number of live cells due to UVA-induced cytotoxicity.
[0229] The preliminary results from the antioxidant capacity assay in hair follicle cells show that compositions M1, M2, and M3 reduced intracellular ROS levels after 24 hours of treatment, as evidenced by decreased fluorescence intensity proportional to ROS accumulation.
[0230] Citation List
[0231] Non-Patent Literature
[0232] - Ye Niu et al.; “Overwiew of the Circadian Clock in the Hair Follicle Cycle” ;
[0233] Biomolecules 2023, vol. 13, 1068
[0234] - Fischer TW, Burmeister G, Schmidt HW, Elsner P. Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial. Br J Dermatol. 2004 Feb;150(2):341-5. doi:
[0235] 10.1111 / j.1365-2133.2004.05685.x. PMID: 14996107.
[0236] - Le Floc'h C, Cheniti A, Connetable S, et al. Effect of a nutritional supplement on hair loss in women. J Cosmet Dermatol. 2015;14(1):76 - 82.) https: / / doi.Org / 10.1111 / jocd.12127.
[0237] - F. Du et al.; “Oxidative stress in hair follicle development and hair growth: signaling pathways, intervening mechanism and potential of natural antioxidants”, J. Cell. Mol Med, 2024, vol. 28: e18486.
Claims
Claims1. A composition for promoting natural hair growth, the prevention and / or reduction of natural hair loss, promoting hair health or any combination thereof, comprising:a) at least a natural extract A selected from the group consisting of Pleurotus ostreatus extract, and Chlorella extract selected from Chlorella vulgaris and Chlorella pyrenoidosa extract;b) at least an amino acid selected from the group consisting of L- Arginine, L- Alanine, L-Glycine, L- Serine, L- Lysine, L- Leucine, and L- Proline; andc) melatonin; or a plant extract B which is Schisandra extract,; or a combination of melatonin with Schisandra extract;wherein promoting hair health means improving one or more properties of hair selected from strength, breakage resistance, hydration, smoothness, gloss, softness, and elasticity.
2. The composition according to claim 1 which is an oral composition.
3. The oral composition according to any of the claims 1-2, which is a liquid oral composition.
4. The composition according to any of the claims 1-3 which comprises:a) the at least natural extract A is selected from the group consisting of Pleurotus ostreatus extract, and Chlorella extract selected from Chlorella vulgaris and Chlorella pyrenoidosa extract;b) the at least an amino acid is selected from the group consisting of L- Arginine, L-Alanine, L-Glycine, L- Serine, and L- Lysine; andc) melatonin;5. The composition according to claim 4 comprising:a) Pleurotus ostreatus extract;b) the at least an amino acid is selected from the group consisting of L- Arginine, and L-Alanine; andc) melatonin.
6. The composition according to any of the claims 1-5, comprises a further compound selected from the group consisting of Pyrroloquinoline quinone disodium, Zinc bisglycinate, L- Hydroxyproline, L- Phenylalanine, L- Isoleucine, Hyaluronic acid, Pyridoxine hydrocloride, L-ascorbic acid, Magnesium bisglycinate, Melissa officinalis extract, Passiflora incarnata extract, and mixtures thereof.
7. The composition according to any of the claims 1-6, wherein natural extract A is in an amount from 5 to 150 mg.
8. The composition according to any of the claims 1-6, wherein the at least an amino acid is in an amount from 2 to 600 mg.
9. The composition according to any of the claims 1-6, wherein melatonin is in an amount from 0.5 to 3 mg and Schisandra extract is in an amount from 20 to 200 mg.
10. Use of a composition as defined in any of the claims 1-9, in the prevention of natural hair loss, in promoting hair health, in promoting natural hair growth, or any combination thereof.
11. Use of the composition according to claim 10, wherein promoting natural hair growth, promoting hair health, the prevention and / or reduction of natural hair loss, or any combination thereof is mediated through regeneration of hair follicles.
12. Use of the composition according to any of the claims 10-11, wherein the composition is administered once a day.
13. Use of the composition according to any of the claims 10-12, wherein the composition is administered between 30 to 60 minutes before going to sleep at nighttime.
14. Use of the composition according to any of the claims 10-13, wherein the composition is administered at nighttime in a regimen which further comprises administering a second composition for promoting hair growth and / or reducing hair loss in daytime.
15. A composition as defined in any of the claims 1-9 in combination with a pharmacological treatment, for use in the prevention of hair loss, in promoting hair growth, or any combination thereof.
16. The composition for use according to claim 15, wherein promoting hair growth, the prevention and / or reduction of hair loss, or any combination thereof is mediated through regeneration of hair follicles.
17. The composition for use according to any of the claims 15-16, wherein the composition is administered once a day.
18. The composition for use according to any of the claims 15-17, wherein thecomposition is administered between 30 to 60 minutes before going to sleep at nighttime.
19. The composition for use according to any of the claims 15-18, wherein the composition is administered at nighttime in a regimen which further comprises administering a second composition for promoting hair growth and / or reducing hair loss in daytime.
20. A kit for promoting hair growth, the prevention and / or reduction of hair loss, promoting hair health; or any combination thereof comprising:a) a composition as defined in any of the claims 1-9 for nighttime administration, b) a composition for promoting hair growth and reducing hair loss for daytime administration; andc) instructions for the administration of the compositions.
